Literature DB >> 9986892

Kawasaki disease complicated by peripheral gangrene.

J S Chang1, J S Lin, C T Peng, C H Tsai.   

Abstract

An 8.5-month-old male infant with Kawasaki disease (KD) received high-dose intravenous immunoglobulin (IVIG) therapy on the fifth day after fever onset. However, multiple peripheral limb ischemias occurred 2 days later. Accordingly, heparin followed by dipyridamole was administered. Aside from a small amputation at the tip of the right middle finger, all other digital ischemias resolved. This presentation demonstrates that early recognition and management of peripheral gangrene in KD may keep its sequela to a minimum.

Entities:  

Mesh:

Year:  1999        PMID: 9986892     DOI: 10.1007/s002469900422

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  5 in total

1.  A case of refractory Kawasaki disease complicated by peripheral ischemia.

Authors:  Na Yeon Kim; Deok Young Choi; Mi Jin Jung; In-Sang Jeon
Journal:  Pediatr Cardiol       Date:  2008-05-15       Impact factor: 1.655

2.  The use of corticosteroid therapy in refractory Kawasaki patients.

Authors:  Sulaiman M Al-Mayouf
Journal:  Clin Rheumatol       Date:  2003-12-16       Impact factor: 2.980

3.  Peripheral Gangerene, an Unusual Presentation of Infantile Kawasaki: A Case Report and Literature Review.

Authors:  Fatemeh Tahghighi; Maryam Bakhtiari Koohsorkhi; Vahid Ziaee
Journal:  Case Rep Rheumatol       Date:  2021-04-13

Review 4.  Kawasaki disease complicated by peripheral artery thrombosis: a case report and literature review.

Authors:  Nanjun Zhang; Li Yu; Zhongxian Xiong; Yimin Hua; Hongyu Duan; Lina Qiao; Kaiyu Zhou; Chuan Wang
Journal:  Pediatr Rheumatol Online J       Date:  2022-09-05       Impact factor: 3.413

5.  Kawasaki Disease and Peripheral Gangrene in Infancy.

Authors:  Iran Malekzadeh; Vahid Ziaee; Taravat Sadrosadat; Mohammad-Hassan Moardinejad; Keyhan Sayadpour-Zanjani
Journal:  Iran J Pediatr       Date:  2015-12-23       Impact factor: 0.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.